• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags OxyContin

OxyContin News

Business

McKinsey's $650M Settlement: Addressing Its Role in the Opioid Crisis

Sarah Mitchell 14 Dec, 2024

Consulting firm McKinsey & Co. has agreed to pay $650 million to settle federal charges related to its role in the U.S. opioid crisis, including a strategy to boost OxyContin sales...

Popular News

  • Business

    India's Stock Market: The Most Expensive Globally Despite Strong Fundamentals, Nuvama Reports

    21 Jul, 2025
  • Economy

    Japan's December Retail Sales Dip by 0.7%: A Closer Look at the Economic Impact

    31 Jan, 2025
  • Economy

    Trump Imposes Sweeping Tariffs on Mexico, Canada, and China to Combat Drug Influx

    02 Feb, 2025
  • Crypto

    House Republicans Block Crypto and Defense Bills: A Surprising Turn of Events

    16 Jul, 2025
  • Economy

    Vietnam's Long Thanh International Airport Set to Elevate Asia's Aviation Landscape by 2050

    31 Jul, 2025
  • Business

    Walgreens Reports a Strong 3.9% Sales Growth to $38.6 Billion in Q2, Beating Analysts' Expectations

    09 Apr, 2025
  • Business

    Tesla Accelerates into India: First Showroom Launches in Mumbai with Model Y Starting at Rs 61 Lakh

    15 Jul, 2025
  • Market

    US Stock Markets Dip at Open as Investors Await Federal Reserve's Crucial Rate Decision

    06 May, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.